2,3,4,9-tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonists

Details for Australian Patent Application No. 2005320964 (hide)

Owner Actelion Pharmaceuticals Ltd.

Inventors Riederer, Markus; Fretz, Heinz; Fecher, Anja

Agent A J Park

Pub. Number AU-B-2005320964

PCT Pub. Number WO2006/070325

Priority PCT/ EP2004/014719 27.12.04 EP

Filing date 22 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 15 December 2011

International Classifications

C07D 209/88 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404 (2006.01)

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/070325 Priority application(s): WO2006/070325

15 December 2011 Application Accepted

  Published as AU-B-2005320964

12 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005320976-Biodegradable, super absorbent polymer hydrogels and a method for their preparation

2005320935-Device, system and method for in-vivo examination